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Abstract
The QT interval (QT) is heritable and its prolongation is a risk factor for ventricular tachyarrhythmias and sudden death.
Most genetic studies of QT have examined European ancestral populations; however, the increased genetic diversity in
African Americans provides opportunities to narrow association signals and identify population-specific variants. We
therefore evaluated 6,670 SNPs spanning eleven previously identified QT loci in 8,644 African American participants from
two Population Architecture using Genomics and Epidemiology (PAGE) studies: the Atherosclerosis Risk in Communities
study and Women’s Health Initiative Clinical Trial. Of the fifteen known independent QT variants at the eleven previously
identified loci, six were significantly associated with QT in African American populations (P#1.2061024): ATP1B1, PLN1,
KCNQ1, NDRG4, and two NOS1AP independent signals. We also identified three population-specific signals significantly
associated with QT in African Americans (P#1.3761025): one at NOS1AP and two at ATP1B1. Linkage disequilibrium (LD)
patterns in African Americans assisted in narrowing the region likely to contain the functional variants for several loci. For
example, African American LD patterns showed that 0 SNPs were in LD with NOS1AP signal rs12143842, compared with
European LD patterns that indicated 87 SNPs, which spanned 114.2 Kb, were in LD with rs12143842. Finally, bioinformatic-
based characterization of the nine African American signals pointed to functional candidates located exclusively within
non-coding regions, including predicted binding sites for transcription factors such as TBX5, which has been implicated in
cardiac structure and conductance. In this detailed evaluation of QT loci, we identified several African Americans SNPs that
better define the association with QT and successfully narrowed intervals surrounding established loci. These results
demonstrate that the same loci influence variation in QT across multiple populations, that novel signals exist in African
Americans, and that the SNPs identified as strong candidates for functional evaluation implicate gene regulatory
dysfunction in QT prolongation.
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Introduction
The QT interval (QT), as measured by the resting 12-lead
electrocardiogram (ECG), reflects the duration of ventricular
depolarization and repolarization, providing a non-invasive assess-
ment of an average ventricular action potential. QT prolongation is
an established risk factor for ventricular tachyarrhythmias [1],
coronary heart disease [2], and sudden cardiovascular as well as all-
cause death [3]. Although numerous factors influencing QT have
been identified, including heart rate [4], structural heart disease
[5,6], gender [7,8], age [9], and medication use [10–12], a large
portion of the variance in QT remains unexplained.
Several lines of evidence support a genetic contribution to QT.
Initial evidence was provided by studies of inherited cardiac
arrhythmias including long- and short-QT syndromes, which
identified rare and highly penetrant mutations in ion channel and
ion channel associated genes associated with QT [13]. Family
studies have also reported that ventricular repolarization (as
measured by QT) is heritable [14–17]. In addition, recent
genome-wide association (GWA) studies performed in populations
of predominantly European descent have identified common
SNPs in twelve loci, including NOS1AP, KCNH2, and PLN [18–
23], that influence the distribution of QT.
To date, the majority of published GWA studies examining QT
have been performed in populations of European descent, although
one study also examined an Indian Asian population [23]. It is
therefore unclear whether previously identified QT loci are relevant
in other racial groups such as African Americans or whether there
are population-specific SNPs influencing QT. Furthermore, the
increased genetic diversity in populations of African ancestry
provides opportunities for the narrowing and fine-mapping of loci
identified in European and Indian Asian populations [24]. Fine-
mapping, which includes the dense genotyping of common and rare
SNPs at already established loci, is a helpful next step in the
identification of functional polymorphisms underlying the QT
distribution. For example, dense genotyping can capture rarer SNPs
that may be inadequately represented on frequently used genome-
wide genotyping arrays, and which may have large effects, thereby
potentially helping to explain a larger fraction of the QT heritability
[25], which is estimated to range from 35% to 52% [14–17].
In this study, we evaluated eleven QT loci previously identified
in populations of European and Indian Asian descent in 8,644
African American participants from the Atherosclerosis Risk in
Communities study (ARIC) and Women’s Health Initiative clinical
trial (CT). In addition to testing the previously reported QT index
SNPs at the known loci, we also searched for stronger markers of
the index signal and investigated evidence for independent, novel
SNPs influencing QT in African Americans. For loci associated
with QT in African Americans, we also investigated whether
patterns of linkage disequilibrium (LD) within African Americans
could narrow the regions likely to harbor the biologically relevant
variant. Finally, we queried bioinformatic databases and per-
formed related in silico analyses to identify potential candidate
polymorphisms for follow-up functional evaluation.
Results
Participants are drawn from two separate studies (Methods),
which together comprise 9,702 individuals. After applying the
exclusion criteria (Methods), phenotypic data from 8,644 partic-
ipants are included in this analysis. The majority of participants
are female (86%) and ages range from 45–79 years (Table S1).
Estimates of mean QT and heart rate are consistent across the
studies. Approximately 60% of participants are directly genotyped
on the Metabochip; the remaining 40% have genotypes imputed
from the Affymetrix 6.0 panel (Methods).
Representation of QT loci on the Metabochip and
imputation
The Metabochip, a custom array containing approximately
195,000 SNPs, is designed to facilitate fine-mapping of loci
associated with cardiovascular and metabolic traits, including QT,
blood pressure, cholesterol, type 2 diabetes, and anthropometrics.
To identify and fine-map signals associated with QT in African
Americans, 6,670 SNPs from eleven previously identified QT loci
represented on the Metabochip are examined (Table S2;
Methods). The number of SNPs at each locus with minor allele
frequency (MAF) estimates $1% ranges from 51 to 1,371,
corresponding to regions spanning 67 Kb to 664 Kb in size
(median size: 275 Kb).
On average, imputation quality for metabochip SNPs imputed
in WHI SNP Health Association Resource (SHARe) participants
(n = 3,531) is high across the 11 loci, with the exception of
RNF207, KCNH2, and KCNQ1 (Table S2). As described in the
Methods, SNPs with imputation quality scores ,0.95 are
discarded.
Association of QT loci in African Americans
The six published GWA studies of QT (five studies of European
ancestral populations, one study of European and Indian Asian
ancestral populations) reported 25 index SNPs (P#5.061028,
QT Fine-Mapping in African Americans
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Table 1; D’ estimates provided in Table S3) across eleven loci,
which together represent fifteen independent signals (at r2$0.20 in
European ancestry populations). The fifteen signals include three
independent signals at NOS1AP and two independent signals at
both PLN and KCNH2.
We first test the fifteen independent signals for association with
QT in African Americans. Specifically, we evaluate the index
SNPs for each of the fifteen independent signals as well as all SNPs
in LD with the index SNPs (r2$0.20 using European ancestral LD
patterns) to determine whether any of the fifteen independent
signals generalize to African Americans. The significance criterion,
aa = 1.20610
24, is based on the number of tag SNPs in African
Americans that capture (r2$0.80, using African American LD
patterns) all SNPs that are correlated with the index SNPs
(r2$0.20; determined using European ancestral LD patterns; see
Methods).
Six of the fifteen independent signals are significantly associated
with QT in African Americans (Table 1): NOS1AP independent
signals 1 and 2, ATP1B1, PLN independent signal 1, KCNQ1, and
NDRG4. Of those that are not significantly associated with QT (P-
value.1.2061024), estimates for index SNPs representing the two
KCNH2 independent signals as well as the RNF207 index SNP
show a consistent magnitude and direction of effect when
compared to published estimates (Table S4).
The best marker in African Americans for the first NOS1AP
independent signal (rs12143842) and KCNQ1 (rs12296050) is
identical to the European index SNP. For the ATP1B1 and
NDRG4 index SNPs as well as the second NOS1AP independent
signal, the best marker in African Americans shows only a slightly
more significant association than the index signal (,1 order of
magnitude change in the P-value; Table 1). In contrast, at the first
PLN independent signal, the three index SNPs are not significantly
associated with QT in African Americans (P-value range: 0.034–
0.60), although a substantially stronger marker of the index signal
is detected (rs56403768; P-value = 3.861025). In Europeans,
rs56403768 is correlated with the three index SNPs (LD r2 range:
0.68–0.88). However, patterns of correlation are weaker in African
Americans (LD r2 range: 0.39–0.50).
We then evaluate evidence for additional independent signals at
the eleven previously identified QT loci, focusing on SNPs that are
uncorrelated with the index signals in European populations.
Here, statistical significance is defined using an efficient Monte
Carlo approach that accounts for LD between SNPs at the eleven
previously identified QT loci (ab = 1.37610
25; see Methods).
Eleven SNPs at two loci that are uncorrelated with the index SNPs
(r2#0.20; evaluated using both African American and European
ancestral LD patterns) exceed our significance threshold. Condi-
tional analysis confirms that these eleven SNPs represent three
novel associations, one flanking the NOS1AP locus and two
residing within or nearby ATP1B1 (Table 2; Figures 1 and S1). Of
note, the novel NOS1AP SNP is monomorphic in populations of
European ancestry. Together, the six best markers in African
Americans and the three novel SNPs explain 1.6% of the variance
in heart rate-corrected QT.
Next, we examine whether African American LD patterns can
assist with the narrowing of association signals at the six loci that
generalized to African Americans. An example of variation in LD
patterns by ancestral population is shown by the first NOS1AP
independent signal. Among African Americans, 0 SNPs are
correlated (r2$0.50) with rs12143842, which is the best marker in
African Americans and the index SNP reported by three prior QT
GWA studies (Figure 1; Table 3) [20–22]. This is in contrast to LD
patterns estimated in Europeans for NOS1AP independent signal 1,
where 87 SNPs are correlated with the three index signals that
characterize this independent signal (r2$0.50), representing a
region spanning 114.2 Kb. For the five remaining markers
(Figures 1 and S1, S2, S3, S4), African American populations
exhibit lower levels of LD as compared to European populations
(mean narrowing = 48.2 Kb). Likewise, fine-mapping in African
Americans helped to narrow the association signals for all six loci.
Bioinformatic-based functional characterization of QT
loci
Bioinformatic analysis of the six best markers in African
Americans and the three novel and independent SNPs (Table
S5; Methods) does not identify any correlated non-synonymous
coding variants; instead, all signals harbor variants that occur
solely within non-coding regions with the potential for influencing
cis-regulation (Table S6). Several variants occur within candidate
regulatory elements (promoter regions and DNase hypersensitive
sites in human cardiomyocytes), including three (rs3864884,
rs1646010, and rs27097) that are predicted to have allele-specific
binding affinities for various transcription factors of relevance to
cardiac function (Table S7). Though further functional character-
ization is outside the scope of this study, rs3864884, rs1646010,
rs27097, and rs37036 represent compelling candidates for follow-
up evaluation.
Discussion
In this study composed of approximately 8,600 African
American participants, we evaluated fifteen independent signals
across eleven loci that were previously associated with QT in
populations of European and Indian Asian ancestry at genome-
wide significant levels. For five independent signals – the two
NOS1AP independent signals, ATP1B1, NDRG4, and KCNQ1 – the
best markers in African Americans were either identical to or only
slightly more significant than the index signal. These five markers
Author Summary
The QT interval (QT) provides a measure of a ventricular
action potential, and its prolongation is associated with
sudden death and ventricular arrhythmias. Genome-wide
association studies performed in European populations
have identified common genetic variants that influence
QT. However, it is unclear whether these variants are
relevant in other populations, including African Americans.
The increased genetic diversity in African Americans also
provides opportunities to narrow association signals and
identify candidates for functional evaluation. We therefore
used data from 8,644 African Americans to further
characterize previously identified QT loci. Of the fifteen
known independent QT variants at the eleven previously
identified QT loci, six were associated with QT in African
Americans. We also identified three variants that were
independent from previously reported signals and nar-
rowed intervals flanking association signals using patterns
of linkage disequilibrium. Finally, bioinformatic-based
characterization pointed to candidates located outside
protein coding regions. Our results underscore the utility
of genetic studies in African ancestral populations to
identify novel variants and narrow intervals surrounding
established loci. These results suggest that known QT loci
are important in African Americans and that further
characterization of these loci in other populations may
provide additional insights into the genetic and molecular
mechanisms underlying QT.
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are therefore not considered better signals than the index SNP.
However, for the first PLN locus, the three previously identified
index SNPs were not significantly associated with QT in African
Americans. This result suggests that rs56403768, the best marker
in African Americans, is a better proxy of a biologically important
PLN allele and may help improve localization of the true
association.
In addition to generalizing six previously characterized QT loci,
we also identified three novel and independent signals for NOS1AP
and ATP1B1. Notably, rs79163067, the novel NOS1AP signal, was
monomorphic in European populations. When these three novel
and independent variants were combined with the fifteen
independent QT loci previously identified in populations of
European and Indian Asian ancestry, our results suggest that to-
date at least 18 independent variants influence QT.
Finally, we showed that evaluating LD patterns in admixed
populations such as African Americans assisted with the narrowing
of intervals flanking the putative causal variants. This narrowing
Table 2. Novel and independent SNPs associated with QT at two previously identified QT loci in n = 8,644 African American
participants.
African American
index SNPa Locus Chr Position (Build 36) Allelesb Coded allele frequency P-value
African Americansc Europeansd
rs79163067 NOS1AP 1 160226234 A/G 0.016 0 2.261026
rs12061601 ATP1B1 1 167337074 T/C 0.75 0.86 5.661026
rs10919095e ATP1B1 1 167447481 T/C 0.25 0.48 6.961026
aRestricted to SNPs with minor allele frequency $0.01 that passed quality control and defined as locus-specific SNP with the lowest P-value.
bCoded allele listed first.
cCalculated in the Atherosclerosis Risk in Communities Study.
dCalculated in the Malmö Diet and Cancer Study.
eAdjusted for rs12061601.
Est, estimate. SE, standard error. SNP, single nucleotide polymorphism.
doi:10.1371/journal.pgen.1002870.t002
Figure 1. 2Log P plot for common SNPs at the NOS1AP independent signal 1 and 2 loci. P-values are estimated in African Americans and
are plotted using linkage disequilibrium estimates from African Americans (panels A and C) and Europeans (panels B and D). SNPs are represented by
circles, lines indicate index SNPS previously identified in GWA studies of European and Indian Asian populations, and the large blue diamond is the
best marker in African Americans. Circle color represents correlation with the best marker in African Americans: blue indicates weak correlation and
red indicates strong correlation. Recombination rate is plotted in the background and annotated genes are shown at the bottom of the plot.
doi:10.1371/journal.pgen.1002870.g001
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was particularly evident for the first NOS1AP locus that included
index SNP rs12143842, the most frequently reported SNP in the
QT GWA study literature to-date. Rs12143842 also was the SNP
that explained the majority of variance in heart rate-corrected QT
as well as the best marker in African Americans for the first
NOS1AP independent signal. Rs12143842 has yet to be evaluated
in any functional studies, and although our bioinformatics
characterization did not identify any compelling functional
candidates, the SNP resides less than five Kb from the annotated
NOS1AP promoter. Future studies evaluating the functional
relevance of rs12143842 are clearly indicated.
Of the nine QT SNPs we identified (i.e. the six best markers in
African Americans and the three novel SNPs), all resided in or
were in LD with SNPs residing in candidate long-range regulatory
elements in human cardiomyocytes, annotated promoter regions,
and highly conserved non-coding elements, and as such, strongly
implicate gene regulatory dysfunction in QT prolongation. One of
the more striking predictions was with rs3864884, where the major
allele [C] is predicted to bind an entirely different set of
transcription factors (TFs) than the minor allele [T]. Notably,
only the major allele is predicted to bind Hairy-related TFs, which
are involved in regulating cardiac morphogenesis [26]. The minor
allele is predicted to bind TBX5 and AhR; the former has been
linked to a number of cardiac phenotypes including Holt-Oram
syndrome [27] and atrioventricular conduction [28] and the latter
regulates cardiac size [29], a known risk factor for QT-
prolongation and cardiac sudden death [30]. Consistent with this
prediction, the minor allele is associated with an increased QT in
this population.
We were unable to identify associations with RNF207, SCN5A,
KCNH2, LITAF, LIG3, and KCNJ2 based on our statistical
significance threshold. RNF207 was reported in two previous
QT GWA studies. However, because of design priorities, only 51
SNPs with MAF$1% were available for analysis. Future fine-
mapping efforts in African Americans or other admixed popula-
tions that include denser genotyping of this locus may therefore be
useful.
SCN5A, KCNH2, and LITAF were all reported by two prior
GWA studies of QT. SCN5A also has also been implicated in
GWA studies of PR in populations of European [31] and African
ancestry [28] as well as QRS interval duration in populations of
European descent [32]. Our inability to detect signals at these
three loci may simply reflect inadequate power, especially for
KCNH2, for which estimates of the index SNPs in African
Americans were consistent with the published literature. KCNJ2 is
a biologically plausible locus influencing QT, as it harbors
mutations causing rare, familial forms of long QT syndrome
[33]. Yet, the high P-values and the dense genotyping coverage of
SNPs suggest that KCNJ2 does not influence QT in African
American populations.
The genetic architecture of African Americans and other
admixed populations is on average characterized by lower
correlation between SNPs when compared to European popula-
tions. Such populations therefore are valuable for the fine-
mapping of previously identified loci, as fewer SNPs are expected
to be correlated with the underlying functional variant, which is
expected to be the same in populations of different ethnicity. We
therefore anticipate that future fine-mapping efforts that include
populations with different ethnic backgrounds will be useful for the
further refinement of loci influencing QT as well as the
identification of population-specific variants, as demonstrated by
the current report.
Several limitations of the present study warrant further
consideration in order to inform future efforts for fine-mapping
and functional characterization of QT loci. First, although the
Metabochip includes dense genotyping of most QT loci, it is
possible that the causative variants are not included on the
Metabochip. Second, our functional characterization is based on
in silico analyses and requires experimental validation. Third, the
majority of study participants were female. It is unclear how a
predominantly female population may have influenced the results
presented herein, considering the well-known dependence of QT
on gender [7,8]. Finally, our results, which are consistent with
prior studies [22], show that common SNPs only explain a very
small fraction of the variance in QT, although heritability
estimates suggest a substantial genetic component. These modest
effect sizes corroborate the multifactorial etiology of QT and
demonstrate that substantially greater efforts are required to
explain the ‘‘missing heritability’’. Future efforts with increased
sample sizes that examine rare variants, gene-gene and gene-
environment interactions, and structural variants poorly captured
on existing arrays are clearly needed [34].
In conclusion, our findings provide compelling evidence that the
same genes influence variation in QT across ancestral populations
Table 3. Comparison of linkage disequilibrium patterns between populations of African and European descent for six previously
identified QT loci significantly associated with QT in n = 8,644 African American participants.
African Americans Europeans
Locus Ind. signal
N. SNPs in LD with
best markera,b Region size (Kb)
N. SNPs in LD with
index SNPsa,c Region size (Kb)
Region size
difference (Kb)d
NOS1AP 1 0 0 87 114.2 114.2
2 13 71.8 29 86.4 14.6
ATP1B1 1 24 331.6 28 340.1 8.5
PLN, SLC35F1 1 27 343.7 173 466.0 122.3
KCNQ1 1 7 10.4 19 34.6 24.2
NDRG4 1 57 141.8 65 147.0 5.2
ar2$0.50.
bCalculated using African American LD patterns.
cCalculated using European LD patterns.
dCalculated as (European region size - African American region size (Kb)).
Kb, kilobase. LD, linkage disequilibrium.
doi:10.1371/journal.pgen.1002870.t003
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and that additional, independent signals exist in African Ameri-
cans. Moreover, all SNPs identified as strong candidates for
functional evaluation implicate gene regulatory dysfunction.
Further characterization of these loci, including direct sequencing
and large-scale genotyping in African Americans and other
admixed populations, may provide more information on the
genetic and molecular mechanisms underlying QT.
Materials and Methods
Ethics statement
The Institutional Review Board at all participating institutions
approved the study protocol. This study was conducted according
to the principles expressed in the Declaration of Helsinki.
Study populations
The Population Architecture using Genomics and Epidemiol-
ogy (PAGE) study is a National Human Genome Research
Institute funded effort examining the epidemiologic architecture of
common genetic variants that have been reproducibly associated
with human diseases and traits [35]. The PAGE study consists of a
coordinating center and four consortia with access to large, diverse
population-based studies including three National Health and
Nutrition Examination Surveys, the Multiethnic Cohort, the
WHI, the ARIC study, the Coronary Artery Risk Disease in
Young Adults study, the Cardiovascular Health Study, the
Hispanic Community Health Study/Study of Latinos, the Strong
Heart Study, and the Strong Heart Family Study.
This PAGE Metabochip study included African American
participants from the ARIC and WHI CT studies. Participants
from the other PAGE studies were excluded from this effort due to
the unavailability of ECG measures and/or genotype data.
Genotypes of WHI CT participants were obtained in three
phases: two sets of women were directly genotyped on the
Metabochip platform by PAGE investigators during wave 1
(n = 797) and wave 2 (n = 1,128) and women (n = 3,531) with
Metabochip variants imputed from previous genome-wide SNP
data provided by the WHI SHARe [36]. Participants meeting the
following criteria were excluded from the study: QT unavailable,
atrial fibrillation/atrial flutter on ECG, left or right bundle branch
block on ECG, QRS duration .120 milliseconds, intraventricular
conduction delay on ECG, pacemaker implant antedating ECG,
ancestry outlier, excessive heterozygosity, low call rate, or second
member of first degree relative pair. Further details on the ARIC
and WHI CT studies are provided in Text S1 (Participating
Studies).
QT measurement
For each study, certified technicians digitally recorded resting,
supine (or semi-recumbent), standard 12-lead ECGs at study
baseline for each participant using Marquette MAC PC machines
(GE Healthcare, Milwaukee, WI, USA). The ARIC and WHI CT
studies used comparable procedures for preparing participants,
placing electrodes, recording, transmitting, processing, and con-
trolling quality of the ECGs. QT was measured electronically
using the Marquette 12SL algorithm.
The Metabochip
The Metabochip was a custom Illumina iSELECT array that
contained approximately 195,000 SNPs and was designed to
support large scale follow up of putative associations for
cardiovascular and metabolic traits including QT, blood pressure,
cholesterol, type 2 diabetes, and anthropometrics. Approximately
33% of the Metabochip SNPs were included as replication targets
and 62% for fine-mapping. In total, 257 loci were selected for fine-
mapping, with the surrounding regions totaling 45.5 Mb account-
ing for overlaps (14.2 Mb for the densest fine-mapping regions).
Eleven QT loci identified in previous GWA studies in populations
of European and Asian ancestry were represented on the
Metabochip (Table 1). The only published QT locus that is not
represented on the Metabochip is an intergenic region on 13q14
reported by Marroni et al [19], but not replicated by other
published GWA studies of populations with similar ancestral
backgrounds. SNPs reported in the literature but not genotyped on
the Metabochip (NOS1AP, rs10494366; NDRG4, rs7188697,
rs37062) were represented by proxies, defined as SNPs in high
LD (r2$0.90) with the index SNP using HapMap YRI data.
Genotyping and quality control assessment
Samples were genotyped at the Human Genetics Center of the
University of Texas-Houston and the Translational Genomics
Research Institute for ARIC and WHI, respectively, following
each genotyping center’s standard procedures. HapMap YRI
(Yoruba in Ibadan, Nigeria) samples were also genotyped
independently by each study to facilitate cross-study quality
control. Genotypes were called separately for each study, albeit
with a common protocol and common personnel, with Geno-
meStudio using the GenCall 2.0 algorithm. Because the
Metabochip includes SNPs with much lower MAFs than are
usually called with GenCall, SNPs were recalled using the
GenoSNP genotype-calling algorithm [37]. SNPs with call rates
,95%, Hardy-Weinberg equilibrium P,1026, .1 Mendelian
error (in 30 YRI trios), .2 replication errors, or .3.3% discordant
calls in YRI across genotyping centers or against the HapMap
database were considered quality control failures. Samples with
call rates ,0.95 or an inbreeding coefficient F.0.15 were
excluded from further analysis [38].
Prior to analyses, related participants were identified using
PLINK [39] by estimating identical-by-descent statistics for all
pairs. When apparent first-degree relative pairs were identified,
the member from each pair with the lower call rate was
excluded from further analysis. Principal components of
ancestry were determined using the Eigensoft software [40,41]
and apparent ancestral outliers were excluded from further
analysis.
WHI SHARe imputation
Briefly, n = 1,962 WHI participants who were genotyped on
both the Affymetrix 6.0 and Metabochip genotyping platforms
were used to infer Metabochip genotypes to the n = 8,421
population of WHI participants genotyped on the Affymetrix 6.0
array [36]. Before phasing and imputation, Affymetrix 6.0 SNPs
with genotype call rates ,90%, Hardy-Weinberg P-values,1026,
or MAF,0.01 were removed. Participants with call rates ,95%,
those who demonstrated excess heterozygosity, were part of a first-
degree relative pair, or who were identified as an ancestry outlier
were excluded. This yielded a set of 987,749 SNPs for the 1,962
reference participants. Mean concordance rates for the 23,703
SNPs in common was 99.7%. Haplotypes were reconstructed
using MaCH and were used as a reference to impute Metabochip
data into the 6,459 WHI participants with only Affymetrix 6.0
data. Liu et al., (2012) demonstrated the ability to impute 99.9%
(97.5%, 83.6%, 52.0%, 20.5%) of SNPs with MAF$0.05 (0.03–
0.05, 0.01–0.03, 0.005–0.01, and 0.001–0.005) with average
dosage r2 = 94.7% (92.1%, 89.0%, 83.1%, and 79.7%), respec-
tively. For this analysis, all imputed SNPs with r2,0.95 were
excluded.
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Statistical analysis
To interpret fine-mapping results, LD in our African American
PAGE Metabochip sample was calculated in 500 Kb sliding
windows using PLINK. In addition, Metabochip LD and
frequency information (but not individual-level information) was
provided by the Malmö Diet and Cancer Study on 2,143 control
participants from a Swedish population [42] to facilitate LD and
MAF comparisons to populations of European ancestry. HapMap
CEU LD data were used for previously published GWA studies in
European populations, as not all European index variants were
represented on the Metabochip. Regional association plots use
positions from NCBI build 36. Recombination rates were
estimated from HapMap phase II data.
Linear regression models were used to study the association
between QT and 6,670 SNPs from 11 regions fine-mapped for
QT assuming an additive genetic model and including age, sex,
study center, ancestry principal components, and heart rate as
covariates. Study-specific association results were combined using
an inverse variance meta-analysis approach as implemented in
METAL [43].
For each QT locus, it is expected that SNPs associated with QT
in African Americans will be correlated with the index SNP
reported in Europeans. Therefore, we first identified and tested
SNPs that are correlated (r2$0.20) with the index signals in
Europeans using LD statistics estimated in the Malmö Diet and
Cancer Study. In order to determine the appropriate multiple
testing threshold for declaration of whether the previously
identified signals were significantly associated with QT in African
Americans, i.e. generalizability, we then estimated the number of
tag SNPs needed to capture all common alleles (r2$0.80) using
African American LD patterns. The multiple testing threshold for
declaring generalization was aa = 0.05/415, where 415 = the total
number of tags identified using African American LD patterns.
To identify significant population-specific SNPs influencing QT
that were not correlated with the index signal in Europeans (i.e.
r2,0.20, which was estimated in the Malmö Diet and Cancer
Study), we used an efficient Monte Carlo approach that accounts
for LD between SNPs at the previously identified QT loci
(ab = 1.37610
25) [44]. Conditional analyses were then performed
to determine the number of independent signals the population-
specific SNPs represent. Specifically, analyses were repeated for
each locus including the SNP with the smallest P – value as a
covariate. This approach was performed adjusting for successively
less significant SNPs until no SNPs with P –values lower than
ab = 1.37610
25 were identified. To facilitate comparability with
previous reports examining the proportion of variance in QT
explained by common SNPs, heart rate-corrected QT [45] was
regressed on the six best markers in African Americans and the
three population-specific variants assuming an additive genetic
model and including age, sex, study center, ancestry principal
components as covariates.
Functional categorization of QT loci
For each of the nine QT SNPs (i.e. the six best markers in
African Americans and the three novel SNPs), we identified all
SNPs in LD (r2$0.5) using the genotypes from the African
American population described in this study. We refer to these
SNP sets as Trait Associated SNP (TAS) blocks. We assigned each
TAS to one or more of the functional annotation datasets listed in
Table S5. These datasets are not mutually exclusive. For example,
a TAS can reside in both a candidate regulatory element (dataset
#7) and a CTCF binding site (dataset #10). For TASs that occur
within predicted transcription factor binding sites (datasets #3 and
#8), we calculated transcription factor binding affinity for each
TAS allele using PWM-scan [46], as described previously [47].
For TASs that occur within 39 untranslated regions, we used the
TargetScanS algorithm to determine whether they disrupt likely
microRNA target sites (dataset #5). To define candidate non-
promoter regulatory elements of greatest relevance to QT
(dataset #7), we restricted the analysis of DNase I hypersensitive
sites (open chromatin loci) to only those present in human
cardiomyocytes.
Supporting Information
Figure S1 2Log P plot for common SNPs at the ATP1B1 locus.
P-values are estimated in African Americans and are plotted using
linkage disequilibrium estimates from African Americans (panel A)
and Europeans (panel B). SNPs are represented by circles, lines
indicate index SNPS previously identified in GWA studies of
European and Indian Asian populations, and the large blue diamond
is the best marker in African Americans. Circle color represents
correlation with the best marker in African Americans: blue
indicates weak correlation and red indicates strong correlation.
Recombination rate is plotted in the background and annotated
genes are shown at the bottom of the plot.
(DOCX)
Figure S2 2Log P plot for common SNPs at the PLN
independent signal 1 locus. P-values are estimated in African
Americans and are plotted using linkage disequilibrium estimates
from African Americans (panel A) and Europeans (panel B). SNPs
are represented by circles, lines indicate index SNPS previously
identified in GWA studies of European and Indian Asian
populations, and the large blue diamond is the best marker in
African Americans. Circle color represents correlation with the
best marker in African Americans: blue indicates weak correlation
and red indicates strong correlation. Recombination rate is plotted
in the background and annotated genes are shown at the bottom
of the plot.
(DOCX)
Figure S3 2Log P plot for common SNPs at the KCNQ1locus.
P-values are estimated in African Americans and are plotted using
linkage disequilibrium estimates from African Americans (panel A)
and Europeans (panel B). SNPs are represented by circles, lines
indicate index SNPS previously identified in GWA studies of
European and Indian Asian populations, and the large blue diamond
is the best marker in African Americans. Circle color represents
correlation with the best marker in African Americans: blue
indicates weak correlation and red indicates strong correlation.
Recombination rate is plotted in the background and annotated
genes are shown at the bottom of the plot.
(DOCX)
Figure S4 2Log P plot for common SNPs at the NDRG4 locus.
P-values are estimated in African Americans and are plotted using
linkage disequilibrium estimates from African Americans (panel A)
and Europeans (panel B). SNPs are represented by circles, lines
indicate index SNPS previously identified in GWA studies of
European and Indian Asian populations, and the large blue diamond
is the best marker in African Americans. Circle color represents
correlation with the best marker in African Americans: blue
indicates weak correlation and red indicates strong correlation.
Recombination rate is plotted in the background and annotated
genes are shown at the bottom of the plot.
(DOCX)
Table S1 Demographic characteristics of n = 8,644 African
American participants from four studies.
(DOCX)
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Table S3 Associations with common variants at fifteen previ-
ously reported QT loci across eleven chromosomes in n = 8,644
African American participants.
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Table S4 Associations with common variants at nine previously
reported QT loci that did not generalize to n = 8,644 African
American participants.
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Table S5 Genomic datasets used for bioinformatic character-
ization of QT loci.
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Table S6 Bioinformatic characterization, predicted function,
and correlation with index SNP for nine SNPs associated with QT
detected in n = 8,644 African American participants.
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Table S7 QT functional candidates for evaluation after
bioinformatic analysis using data from n = 8,644 African American
participants.
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